TWI640565B - Polymer latex particle composition containing nano silver particles - Google Patents

Polymer latex particle composition containing nano silver particles Download PDF

Info

Publication number
TWI640565B
TWI640565B TW104135206A TW104135206A TWI640565B TW I640565 B TWI640565 B TW I640565B TW 104135206 A TW104135206 A TW 104135206A TW 104135206 A TW104135206 A TW 104135206A TW I640565 B TWI640565 B TW I640565B
Authority
TW
Taiwan
Prior art keywords
particles
polymer latex
nano silver
latex particles
silver particles
Prior art date
Application number
TW104135206A
Other languages
Chinese (zh)
Other versions
TW201714945A (en
Inventor
李佳芬
陳映彤
張羽萱
呂昆霖
Original Assignee
諾兒朵股份有限公司
嘉藥學校財團法人嘉南藥理大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 諾兒朵股份有限公司, 嘉藥學校財團法人嘉南藥理大學 filed Critical 諾兒朵股份有限公司
Priority to TW104135206A priority Critical patent/TWI640565B/en
Priority to US14/953,196 priority patent/US9777125B2/en
Publication of TW201714945A publication Critical patent/TW201714945A/en
Application granted granted Critical
Publication of TWI640565B publication Critical patent/TWI640565B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/20Compounding polymers with additives, e.g. colouring
    • C08J3/205Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase
    • C08J3/21Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase
    • C08J3/215Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase at least one additive being also premixed with a liquid phase
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0275Containing agglomerated particulates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8117Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/12Powdering or granulating
    • C08J3/128Polymer particles coated by inorganic and non-macromolecular organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/62Coated
    • A61K2800/621Coated by inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/65Characterized by the composition of the particulate/core
    • A61K2800/654The particulate/core comprising macromolecular material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2321/00Characterised by the use of unspecified rubbers
    • C08J2321/02Latex
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2325/00Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring; Derivatives of such polymers
    • C08J2325/02Homopolymers or copolymers of hydrocarbons
    • C08J2325/04Homopolymers or copolymers of styrene
    • C08J2325/06Polystyrene
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

本發明係有關於一種含奈米銀粒子之高分子乳膠顆粒組成物,係包括高分子乳膠顆粒及分散塗覆於高分子乳膠顆粒表面之奈米銀粒子,具有抗菌功能。 The invention relates to a polymer latex particle composition containing nano silver particles, which comprises polymer latex particles and nano silver particles dispersed and coated on the surface of the polymer latex particles, and has an antibacterial function.

Description

一種含奈米銀粒子之高分子乳膠顆粒組成物 Polymer latex particle composition containing nano silver particles

本發明係有關於一種含奈米銀粒子之高分子乳膠(polymer latex)顆粒組成物,尤其係指藉由特定條件製備得到的高分子乳膠顆粒組成物,其表面均勻且牢固地塗覆有一層奈米銀。藉此,本發明之乳膠顆粒具有良好的抗菌活性,不僅可以取代化妝品中防腐劑之添加,亦可解決微小的奈米銀穿過皮膚進入人體細胞之問題,並且可使該銀粒子達到奈米級分散,增進其抗菌功效。 The present invention relates to a polymer latex particle composition containing nano silver particles, in particular to a polymer latex particle composition prepared by specific conditions, the surface of which is uniformly and firmly coated with a layer. Nano silver. Thereby, the latex particles of the invention have good antibacterial activity, can not only replace the addition of preservatives in cosmetics, but also solve the problem that tiny nano silver penetrates into the human cells through the skin, and can make the silver particles reach the nanometer. Disperse the grade to enhance its antibacterial effect.

近年來,化妝保養品已成為愛美人士每天不可或缺的生活必需品之一,業者為延長化妝保養品的使用期限,必需在化妝保養品中添加化學抗菌劑或防腐劑以提高保存年限。最常添加在化妝保養品的防腐劑例如對羥基苯甲酸酯(Paraben)、苯氧乙醇(Phenoxyethanol)、安息香酸(苯甲酸,Benzoic acid)、山梨酸(Sorbic acid)等有機化學物,且具有良好的抗菌效果,但經過長期使用而累積超過一定劑量時,仍然有造成肌膚過敏和毒性的疑慮。 In recent years, cosmetic care products have become an indispensable daily necessities for beauty lovers. In order to extend the life of cosmetic products, it is necessary to add chemical antibacterials or preservatives to cosmetic products to improve the shelf life. Preservatives most commonly added to cosmetic care products such as parabens, Phenoxyethanol, Benzoic acid, sorbic acid, and other organic chemicals, and It has a good antibacterial effect, but when it accumulates over a certain dose after long-term use, there are still doubts about skin allergies and toxicity.

除了化學合成的有機抗菌劑或防腐劑之外,目前最廣為人知的無機類抗菌劑為奈米銀粒子,其具有極佳的除臭及殺菌效果,且可耐高溫。除此之外,奈米銀粒子亦可避免使用二氧化鈦光觸媒抗菌時需接觸紫外光之缺失。據此,目前已有多項發明係藉由將奈米 粒子結合到不同的基材上,使基材具備附加的抗菌功能。 In addition to chemically synthesized organic antibacterial agents or preservatives, the most widely known inorganic antibacterial agents are nano silver particles, which have excellent deodorizing and bactericidal effects and are resistant to high temperatures. In addition, the nano silver particles can also avoid the need to contact the absence of ultraviolet light when using titanium dioxide photocatalyst for antibacterial. According to this, there are many inventions by using nano The particles are bonded to different substrates to provide additional antimicrobial activity to the substrate.

舉例而言,中華民國專利公告第I455778號「含基材表面結合金屬奈米粒子的製造方法」,即揭示一種基材表面結合金屬奈米粒子的製造方法,包含下列步驟:將一預定材質的基材浸入一含有預定濃度之金屬離子的鹽類溶液,使該鹽類溶液中的金屬離子附著到該基材上,再將該基材取出,並將一含有一預定還原劑的反應液添加至該基材上,及提供一能量作用於該基材,使附著在該基材上的金屬離子被還原為金屬奈米粒子,最後,以一預定方法使該基材乾燥,製得結合金屬奈米粒子的基材製品,藉此所製出的製品不易殘留對人體有害的化學成分,而不需再以複雜的分離程序處理;中華民國專利公告第I495481號「聚矽氧複合粒子及其製造方法、以及化妝料」,即揭示一種可添加於體香劑化妝料的聚矽氧複合粒子,其特徵在於100質量份的聚矽氧彈性體球狀粒子塗覆有0.5~25質量份的聚矽氧樹脂,其中該聚矽氧彈性體球狀粒子的平均粒徑為0.1~100μm,以及該聚矽氧樹脂係具有有機矽倍半氧烷單位作為主成分,且含有平均粒徑為100nm以下之無機微粒子;以及中華民國專利公告第I455718號「用於抗菌之奈米銀粒子/黏土複合物及其製造方法」,揭示一種可應用於生物、醫藥、化學、化工、材料等領域(例如抗菌及燒燙傷醫療)的奈米銀粒子/黏土複合物,其係為一粉體,包括金屬粒子及片狀無機黏土,其中該片狀無機黏土之長寬比為100~1000,並作為該金屬粒子之載體,以使該金屬粒子達到奈米級之分散,該抗菌之奈米金屬粒子/無機黏土複合物之大小為5~100nm;其中該片狀無機黏土為皂土或奈米矽片,且該片狀無機黏土為皂土時,奈米金屬粒子與黏土重量比為1:100~1:13.83或1:6.944~100:1;該片狀無機黏土為奈米矽片時,奈米金屬粒子與黏土重量比為1:13.43~100:1;該金屬係選自銀所組 成之群組。 For example, the method of manufacturing a substrate-containing surface-bonded metal nanoparticle according to the Patent Publication No. I455778 of the Republic of China, discloses a method for producing a surface-bonded metal nanoparticle of a substrate, comprising the steps of: The substrate is immersed in a salt solution containing a predetermined concentration of metal ions, the metal ions in the salt solution are attached to the substrate, the substrate is taken out, and a reaction solution containing a predetermined reducing agent is added. Adhering to the substrate, and providing an energy to the substrate, causing metal ions attached to the substrate to be reduced to metal nanoparticles, and finally, drying the substrate in a predetermined manner to obtain a bonding metal The base material of the nanoparticle, whereby the product produced is not easy to leave a chemical component harmful to the human body, and does not need to be treated by a complicated separation procedure; the Republic of China Patent Publication No. I495481 "Polyoxime composite particles and The manufacturing method and the cosmetic material disclose a polyfluorene-oxygen composite particle which can be added to the deodorant cosmetic, and is characterized in that 100 parts by mass of the polythene oxide elastomer spherical particles It is coated with 0.5 to 25 parts by mass of a polyoxyxene resin, wherein the polyfluorene oxide spherical particles have an average particle diameter of 0.1 to 100 μm, and the polyfluorene oxide resin has an organic germanium sesquioxane unit as a main component. Ingredients, and inorganic fine particles having an average particle diameter of 100 nm or less; and the Republic of China Patent Publication No. I455718 "Nano-silver particles/clay composites for antibacterial use and a method for producing the same", which disclose a method applicable to biology, medicine, Nano-silver particles/clay composites in the fields of chemistry, chemical engineering, materials, etc. (such as antibacterial and scald medical treatment), which are a powder, including metal particles and flaky inorganic clay, wherein the length and width of the flaky inorganic clay a ratio of 100 to 1000, and as a carrier of the metal particles, so that the metal particles reach nanometer-scale dispersion, the size of the antibacterial nano metal particles/inorganic clay composite is 5 to 100 nm; wherein the sheet-like inorganic When the clay is bentonite or nano-powder, and the flaky inorganic clay is bentonite, the weight ratio of the nano metal particles to the clay is 1:100~1:13.83 or 1:6.944~100:1; the flaky inorganic When the clay is a nano-slice, M clay particles and metal weight ratio of 1: 13.43 to 100: 1; a metal selected from the group of silver Into the group.

根據文獻搜尋結果可知,將奈米銀粒子結合到不同基材上之運用雖然很多,但如何達到使奈米銀粒子均勻結合於基材上,仍須視不同的製備方式而定。爰此,如何研發製作出更佳的含奈米銀粒子聚苯乙烯乳膠顆粒作為抗菌劑,乃為相關領域發明人亟需突破之方向。 According to the literature search results, although there are many applications for bonding nano silver particles to different substrates, how to achieve uniform bonding of nano silver particles to a substrate depends on different preparation methods. Therefore, how to develop and produce better nano-silver particle polystyrene latex particles as an antibacterial agent is an urgent need for the inventors in related fields to break through.

本發明主要目的為提供一種藉由特定條件製備得到的乳膠顆粒,其表面係均勻且牢固的黏著、分布有奈米銀。藉此,本發明製得之乳膠顆粒具有良好的抗菌活性,可用以當作防腐劑添加於化妝品。 The main object of the present invention is to provide a latex particle prepared by a specific condition, the surface of which is uniformly and firmly adhered and distributed with nano silver. Thereby, the latex particles obtained by the present invention have good antibacterial activity and can be added to the cosmetic as a preservative.

為了達到上述實施目的,本發明一種含奈米銀粒子之高分子乳膠顆粒組成物,其係包括高分子乳膠顆粒及分散塗覆於高分子乳膠顆粒表面之奈米銀粒子,其中高分子乳膠顆粒之直徑為大於50nm,奈米銀粒子之直徑為1~500nm,且高分子乳膠顆粒與奈米銀粒子重量百分比為1000:1至1:1。 In order to achieve the above-mentioned object, the present invention relates to a polymer latex particle composition containing nano silver particles, which comprises polymer latex particles and nano silver particles dispersed on the surface of the polymer latex particles, wherein the polymer latex particles The diameter is greater than 50 nm, the diameter of the nano silver particles is 1 to 500 nm, and the weight percentage of the polymer latex particles and the nano silver particles is 1000:1 to 1:1.

於本發明之一實施例中,高分子乳膠顆粒可例如為聚苯乙烯(polystyrene)乳膠顆粒、聚甲基丙烯酸甲酯(polymethylmethacrylate)乳膠顆粒、苯乙烯與甲基丙烯酸甲酯共聚物之乳膠顆粒、苯乙烯與甲基丙烯酸正丁酯共聚物之乳膠顆粒、甲基丙烯酸甲酯與甲基丙烯酸正丁酯共聚物之乳膠顆粒。 In one embodiment of the present invention, the polymer latex particles may be, for example, polystyrene latex particles, polymethylmethacrylate latex particles, latex particles of styrene and methyl methacrylate copolymer. Latex particles of a copolymer of styrene and n-butyl methacrylate, latex particles of a copolymer of methyl methacrylate and n-butyl methacrylate.

於本發明之一實施例中,含奈米銀粒子之高分子乳膠顆粒組成物係具有球狀結構或橢圓形結構;若高分子乳膠顆粒為聚苯乙烯乳膠顆粒,則組成物之製備方法可例如為:將含聚苯乙烯乳膠顆粒懸浮液與硝酸銀(AgNO3)水溶液均勻混合以形成一混合溶液,並於溫度90℃作用1小時;以及將混合溶液降溫至80℃,再加入檸檬 酸鈉水溶液於混合溶液中作用0.5小時,以得到表面塗覆有奈米銀粒子之聚苯乙烯乳膠顆粒;其中含聚苯乙烯乳膠顆粒懸浮液係由3.8wt%聚苯乙烯乳膠顆粒及剩餘重量百分比的水所組成。 In one embodiment of the present invention, the polymer latex particle composition containing nano silver particles has a spherical structure or an elliptical structure; if the polymer latex particles are polystyrene latex particles, the preparation method of the composition may be For example, the polystyrene latex particle suspension is uniformly mixed with an aqueous solution of silver nitrate (AgNO 3 ) to form a mixed solution, and is allowed to act at a temperature of 90 ° C for 1 hour; and the mixed solution is cooled to 80 ° C, and then sodium citrate is added. The aqueous solution was allowed to act in the mixed solution for 0.5 hours to obtain polystyrene latex particles coated with nano silver particles; wherein the polystyrene latex particle suspension was composed of 3.8 wt% polystyrene latex particles and the remaining weight percentage Made up of water.

於本發明之一實施例中,含奈米銀粒子之高分子乳膠顆粒組成物可用於抑制革蘭氏陽性菌、革蘭氏陰性菌及真菌之生長;藉此,含奈米銀粒子之高分子乳膠顆粒組成物可用於化妝品原料組成物及醫藥組成物,作為抑菌劑或防腐劑。 In an embodiment of the present invention, the polymer latex particle composition containing nano silver particles can be used for inhibiting the growth of Gram-positive bacteria, Gram-negative bacteria and fungi; thereby, the height of the silver-containing particles is high. The molecular latex particle composition can be used as a cosmetic raw material composition and a pharmaceutical composition as a bacteriostatic agent or a preservative.

第一圖:本發明其一具體實施例所製得含奈米銀粒子聚苯乙烯乳膠顆粒之外觀型態圖。 First Figure: Appearance pattern of nano-silver particle-containing polystyrene latex particles prepared in accordance with one embodiment of the present invention.

第二圖:本發明其二具體實施例所製得含奈米銀粒子聚苯乙烯乳膠顆粒之外觀型態圖。 Fig. 2 is a view showing the appearance of a nano-silver particle-containing polystyrene latex particle obtained by the second embodiment of the present invention.

第三圖:本發明其三具體實施例所製得含奈米銀粒子聚苯乙烯乳膠顆粒之外觀型態圖。 Fig. 3 is a view showing the appearance of a nano-silver particle-containing polystyrene latex particle obtained by the three specific embodiments of the present invention.

第四圖:本發明其四具體實施例所製得含奈米銀粒子聚苯乙烯乳膠顆粒之外觀型態圖。 Fig. 4 is a view showing the appearance of a nano-silver particle-containing polystyrene latex particle obtained by four specific embodiments of the present invention.

第五圖:本發明其五具體實施例所製得含奈米銀粒子聚苯乙烯乳膠顆粒之外觀型態圖。 Fig. 5 is a view showing the appearance of a nano-silver particle-containing polystyrene latex particle obtained by the fifth embodiment of the present invention.

第六圖:本發明含奈米銀粒子聚苯乙烯乳膠顆粒之抑菌濃度分析圖。 Fig. 6 is a graph showing the inhibition concentration of the nano-silver particle polystyrene latex particles of the present invention.

本發明之目的及其結構功能上的優點,將依據以下圖面所示之結構,配合具體實施例予以說明,俾使審查委員能對本發明有更深入且具體之瞭解。 The object of the present invention and its structural and functional advantages will be explained in conjunction with the specific embodiments according to the structure shown in the following drawings, so that the reviewing committee can have a more in-depth and specific understanding of the present invention.

本發明一種含奈米銀粒子之高分子乳膠顆粒組成物,其係包括高分子乳膠顆粒及分散塗覆於高分子乳膠顆粒表面之奈米銀粒 子,其中高分子乳膠顆粒之直徑為大於50nm,奈米銀粒子之直徑為1~500nm,且高分子乳膠顆粒與奈米銀粒子重量百分比為1000:1至1:1。 The invention relates to a polymer latex particle composition containing nano silver particles, which comprises polymer latex particles and nano silver particles dispersed on the surface of the polymer latex particles. The polymer latex particles have a diameter of more than 50 nm, the nano silver particles have a diameter of 1 to 500 nm, and the polymer latex particles and the nano silver particles have a weight percentage of 1000:1 to 1:1.

上述含奈米銀粒子之高分子乳膠顆粒組成物為球狀結構或橢圓形結構;高分子乳膠顆粒為聚苯乙烯(polystyrene)乳膠顆粒、聚甲基丙烯酸甲酯(polymethylmethacrylate)乳膠顆粒或聚甲基丙烯酸正丁酯(poly-n-butyl methacrylate)乳膠顆粒、苯乙烯與甲基丙烯酸甲酯共聚物之乳膠顆粒、苯乙烯與甲基丙烯酸正丁酯共聚物之乳膠顆粒、甲基丙烯酸甲酯與甲基丙烯酸正丁酯共聚物之乳膠顆粒…等;若高分子乳膠顆粒為聚苯乙烯乳膠顆粒,則組成物可例如以下述方法製備而得:將含聚苯乙烯乳膠顆粒懸浮液(可例如由3.8wt%聚苯乙烯乳膠顆粒及剩餘重量百分比的水所組成)與硝酸銀(AgNO3)水溶液均勻混合以形成一混合溶液,並於溫度90℃作用1小時;以及將混合溶液降溫至80℃,再加入檸檬酸鈉水溶液於混合溶液中作用0.5小時,以得到表面塗覆有奈米銀粒子之聚苯乙烯乳膠顆粒,係具有抑制細菌(如革蘭氏陽性菌與革蘭氏陰性菌)及真菌生長的能力,因此可添加於化妝品原料組成物及醫藥組成物。 The polymer latex particle composition containing the nano silver particles is a spherical structure or an elliptical structure; the polymer latex particles are polystyrene latex particles, polymethylmethacrylate latex particles or polymethyl Latex particles of poly-n-butyl methacrylate, latex particles of styrene and methyl methacrylate copolymer, latex particles of styrene and n-butyl methacrylate copolymer, methyl methacrylate Latex particles copolymerized with n-butyl methacrylate, etc.; if the polymer latex particles are polystyrene latex particles, the composition can be prepared, for example, by the following method: a suspension containing polystyrene latex particles ( For example, consisting of 3.8 wt% polystyrene latex particles and residual weight percent of water) uniformly mixed with an aqueous solution of silver nitrate (AgNO 3 ) to form a mixed solution, which is allowed to act at a temperature of 90 ° C for 1 hour; and the mixed solution is cooled to 80. °C, and then added an aqueous solution of sodium citrate in the mixed solution for 0.5 hours to obtain polystyrene latex particles coated with nano silver particles. Inhibit the bacteria (e.g., gram-positive bacteria and Gram-negative bacteria) and fungal growth ability, and therefore can be added to the raw material composition cosmetic and pharmaceutical compositions.

在此值得注意的是,本案發明人於同日申請有另一申請案『一種含奈米銀粒子高分子乳膠顆粒之製備方法』,在此不詳細說明,特將其所有內容包含於此作為參考。 It is worth noting here that the inventor of the present invention applied for another application "a method for preparing nano-silver particle polymer latex particles" on the same day, which is not described in detail herein, and all of its contents are hereby incorporated by reference. .

此外,藉由下述具體實施例,可進一步證明本發明可實際應用之範圍,但不意欲以任何形式限制本發明之範圍。 In addition, the scope of the invention may be further exemplified by the following specific examples, which are not intended to limit the scope of the invention.

實施例一:製備聚苯乙烯乳膠顆粒Example 1: Preparation of polystyrene latex particles

聚苯乙烯乳膠顆粒合成步驟為(1)先將1.9g聚醚醯亞胺(polyethylenimine,PEI)、30g甲醇及1g去離子水混合均勻,再置入反應槽(低速攪拌);(2)取0.3g起始劑AIBN (Azobisisobutyronitrile)溶於15g甲醇以配製成AIBN甲醇溶液;(3)秤取10g苯乙烯(styrene)加入反應槽中與步驟(1)溶液一同攪拌,並加溫至70℃約15分鐘;(4)將步驟(2)均勻溶解的AIBN甲醇溶液快速倒入反應槽中,維持溫度70℃作用8小時,以得到含聚苯乙烯乳膠顆粒的乳狀溶液(PS latex emulsion);以及(5)以離心方式純化聚苯乙烯乳膠顆粒,其平均粒徑大於100nm(約為100~2000nm)。 The steps of synthesizing the polystyrene latex particles are as follows: (1) first mixing 1.9 g of polyethylenimine (PEI), 30 g of methanol and 1 g of deionized water, and then placing them in a reaction tank (low speed stirring); (2) taking 0.3g initiator AIBN (Azobisisobutyronitrile) is dissolved in 15g of methanol to prepare AIBN methanol solution; (3) 10g of styrene is added to the reaction tank and stirred with the solution of step (1), and heated to 70 ° C for about 15 minutes; 4) rapidly distilling the AIBN methanol solution uniformly dissolved in the step (2) into the reaction tank, maintaining the temperature at 70 ° C for 8 hours to obtain a PS latex emulsion containing polystyrene latex particles; and (5) The polystyrene latex particles are purified by centrifugation and have an average particle diameter of more than 100 nm (about 100 to 2000 nm).

實施例二Embodiment 2

請參閱表一,本實施例含奈米銀粒子聚苯乙烯乳膠顆粒合成步驟為(1)取實施例一製得之1g聚苯乙烯乳膠顆粒(PS乳膠顆粒)與25克去離子水混合均勻,以形成聚苯乙烯乳膠顆粒懸浮液;(2)將混合均勻的聚苯乙烯乳膠顆粒懸浮液置入反應槽,在不接冷凝管及通氮氣下,將溫度升至90℃並持續攪拌;(3)將0.1g硝酸銀(AgNO3)與5g去離子水混合以製得硝酸銀水溶液;(4)於溫度90℃,將硝酸銀水溶液加入反應槽中(此時反應槽溶液會逐漸變成鵝黃色溶液),以形成一混合溶液,並作用1小時;(5)將混合溶液降溫至85℃之後,再加入檸檬酸鈉水溶液(1.94克檸檬酸鈉溶於10克去離子水),繼續反應10分鐘使溶液慢慢變成黑色狀態,即得到表面塗覆有奈米銀粒子之聚苯乙烯乳膠顆粒,其中聚苯乙烯乳膠顆粒之平均粒徑為390~990nm,奈米銀粒子之平均粒徑為5~100nm。利用穿透式電子顯微鏡(Transmission Electron Microscopy;TEM)觀察的結果請參閱第一圖,因為加入檸檬酸鈉後,只反應10分鐘,反應的時間太短,使得所合成的銀顆粒數量太少,且銀顆粒來不及吸附在PS乳膠顆粒上,所以無法佈滿整個PS乳膠顆粒的表面,有些PS乳膠顆粒的表面呈現裸露的現象。 Referring to Table 1, the synthesis steps of the nano silver particle-containing polystyrene latex particles in the present embodiment are as follows: (1) 1 g of polystyrene latex particles (PS latex particles) obtained in the first embodiment are uniformly mixed with 25 g of deionized water. To form a polystyrene latex particle suspension; (2) placing a uniformly mixed polystyrene latex particle suspension into the reaction tank, raising the temperature to 90 ° C without stirring the condenser and flowing nitrogen; and continuously stirring; (3) 0.1g of silver nitrate (AgNO 3 ) is mixed with 5g of deionized water to prepare an aqueous solution of silver nitrate; (4) adding a silver nitrate aqueous solution to the reaction tank at a temperature of 90 ° C (the reaction tank solution gradually turns into a goose yellow solution) ), to form a mixed solution, and for 1 hour; (5) after the mixed solution is cooled to 85 ° C, then add sodium citrate aqueous solution (1.94 grams of sodium citrate dissolved in 10 grams of deionized water), continue the reaction for 10 minutes The solution is slowly turned into a black state, that is, a polystyrene latex particle having a surface coated with nano silver particles, wherein the average particle diameter of the polystyrene latex particles is 390 to 990 nm, and the average particle diameter of the nano silver particles is 5 ~100nm. For the results observed by Transmission Electron Microscopy (TEM), please refer to the first figure. After adding sodium citrate, it only reacts for 10 minutes, and the reaction time is too short, so that the amount of silver particles synthesized is too small. And the silver particles are not enough to be adsorbed on the PS latex particles, so the surface of the entire PS latex particles cannot be covered, and the surface of some PS latex particles is bare.

表一 Table I

實施例三Embodiment 3

請參閱表二,本實施例含奈米銀粒子聚苯乙烯乳膠顆粒合成步驟為(1)取實施例一製得之1g聚苯乙烯乳膠顆粒(PS乳膠顆粒)與25克去離子水混合均勻,以形成聚苯乙烯乳膠顆粒懸浮液;(2)將混合均勻的聚苯乙烯乳膠顆粒懸浮液置入反應槽,在不接冷凝管及通氮氣下,將溫度升至90℃~95℃並持續攪拌;(3)將0.1g硝酸銀(AgNO3)與5g去離子水混合以製得硝酸銀水溶液;(4)於溫度90℃~95℃,將硝酸銀水溶液加入反應槽中(此時反應槽溶液會逐漸變成鵝黃色溶液),以形成一混合溶液,並作用1小時;(5)將混合溶液降溫至80℃之後,再加入檸檬酸鈉水溶液(1.94克檸檬酸鈉溶於10克去離子水),繼續反應20分鐘使溶液慢慢變成黑色狀態,即得到表面塗覆有奈米銀粒子之聚苯乙烯乳膠顆粒,其中聚苯乙烯乳膠顆粒之平均粒徑為390~990nm,奈米銀粒子之平均粒徑為5~100nm。利用穿透式電子顯微鏡(TEM)觀察的結果請參閱第二圖,因為加入檸檬酸鈉後,只反應20分鐘,反應的時間太短,使得所合成的銀顆粒數量太少;另一方面,因反應溫度太高,所以銀顆粒迅速形成,使得銀顆粒來不及吸附在PS乳膠顆粒上,所以無法佈滿整個PS乳膠顆粒的表面,有些PS乳膠顆粒的表面呈現裸露的現象。進一步經過測試,若將步驟(5)加入檸檬酸鈉後的反應時間拉長為30分鐘,亦得到類似的結果(圖中未顯示)。因此,有必要再測試不同的條件。 Referring to Table 2, the synthesis steps of the nano silver particle-containing polystyrene latex particles in this embodiment are as follows: (1) 1 g of polystyrene latex particles (PS latex particles) obtained in the first embodiment are uniformly mixed with 25 g of deionized water. To form a suspension of polystyrene latex particles; (2) placing a uniformly mixed suspension of polystyrene latex particles in a reaction tank, raising the temperature to 90 ° C to 95 ° C without a condenser and nitrogen gas Continuous stirring; (3) 0.1 g of silver nitrate (AgNO 3 ) is mixed with 5 g of deionized water to prepare an aqueous solution of silver nitrate; (4) adding a silver nitrate aqueous solution to the reaction tank at a temperature of 90 ° C to 95 ° C (at this time, the reaction tank solution) Will gradually become a goose yellow solution) to form a mixed solution and act for 1 hour; (5) after the mixed solution is cooled to 80 ° C, then add sodium citrate aqueous solution (1.94 g of sodium citrate dissolved in 10 g of deionized water) ), the reaction is continued for 20 minutes to slowly turn the solution into a black state, that is, a polystyrene latex particle having a surface coated with nano silver particles, wherein the average particle diameter of the polystyrene latex particles is 390 to 990 nm, and the nano silver particles are obtained. The average particle size is 5 to 100 nm. For the results observed by a transmission electron microscope (TEM), please refer to the second figure. After adding sodium citrate, the reaction is only 20 minutes, and the reaction time is too short, so that the amount of silver particles synthesized is too small; on the other hand, Since the reaction temperature is too high, the silver particles are rapidly formed, so that the silver particles are not adsorbed on the PS latex particles, so that the surface of the entire PS latex particles cannot be covered, and the surface of some of the PS latex particles is bare. Further testing, if the reaction time after adding the sodium citrate to the step (5) was extended to 30 minutes, similar results were obtained (not shown). Therefore, it is necessary to test different conditions.

實施例四Embodiment 4

請參閱表三,本實施例含奈米銀粒子聚苯乙烯乳膠顆粒合成步驟為(1)取實施例一製得之1g聚苯乙烯乳膠顆粒(PS乳膠顆粒)與25克去離子水混合均勻,以形成聚苯乙烯乳膠顆粒懸浮液;(2)將混合均勻的聚苯乙烯乳膠顆粒懸浮液置入反應槽,在不接冷凝管及通氮氣下,將溫度升至90℃並持續攪拌;(3)將0.3g硝酸銀(AgNO3)與15g去離子水混合以製得硝酸銀水溶液;(4)於溫度90℃,將硝酸銀水溶液加入反應槽中(此時反應槽溶液會逐漸變成鵝黃色溶液),以形成一混合溶液,並作用1.5小時;(5)將混合溶液降溫至80℃之後,再加入檸檬酸鈉水溶液(5.82克檸檬酸鈉溶於30克去離子水),繼續反應30分鐘使溶液慢慢變成黑色狀態,即得到表面塗覆有奈米銀粒子之聚苯乙烯乳膠顆粒。利用穿透式電子顯微鏡(TEM)觀察的結果請參閱第三圖,由於硝酸銀和檸檬酸鈉的量加入過多,且加入硝酸銀後反應1.5小時,反應的時間較久,因此反應所產生的銀過多,以至於許多銀都聚集在一起。 Referring to Table 3, the synthesis steps of the nano silver particle-containing polystyrene latex particles in this embodiment are as follows: (1) 1 g of polystyrene latex particles (PS latex particles) obtained in the first embodiment are uniformly mixed with 25 g of deionized water. To form a polystyrene latex particle suspension; (2) placing a uniformly mixed polystyrene latex particle suspension into the reaction tank, raising the temperature to 90 ° C without stirring the condenser and flowing nitrogen; and continuously stirring; (3) mixing 0.3 g of silver nitrate (AgNO 3 ) with 15 g of deionized water to prepare an aqueous solution of silver nitrate; (4) adding a silver nitrate aqueous solution to the reaction tank at a temperature of 90 ° C (the reaction tank solution gradually becomes a goose yellow solution) ) to form a mixed solution and act for 1.5 hours; (5) after the mixed solution is cooled to 80 ° C, then add sodium citrate aqueous solution (5.82 g of sodium citrate dissolved in 30 g of deionized water), continue the reaction for 30 minutes The solution was slowly turned into a black state, that is, a polystyrene latex particle having a surface coated with nano silver particles was obtained. For the results observed by a transmission electron microscope (TEM), please refer to the third figure. Since the amount of silver nitrate and sodium citrate is too much, and the reaction is carried out for 1.5 hours after adding silver nitrate, the reaction takes a long time, so the reaction produces too much silver. So many silvers are gathered together.

實施例五Embodiment 5

請參閱表四,本實施例含奈米銀粒子聚苯乙烯乳膠顆粒合成步驟為(1)取實施例一製得之1g聚苯乙烯乳膠顆粒(PS乳膠顆粒)與25克去離子水混合均勻,以形成聚苯乙烯乳膠顆粒懸浮液;(2)將混合均勻的聚苯乙烯乳膠顆粒懸浮液置入反應槽,在不接冷凝管及通氮氣下,將溫度升至90℃並持續攪拌;(3)將0.3g硝酸銀(AgNO3)與15g去離子水混合以製得硝酸銀水溶液;(4)於溫度90℃,將硝酸銀水溶液加入反應槽中(此時反應槽溶液會逐漸變成鵝黃色溶液),以形成一混合溶液,並作用1小時;(5)將混合溶液降溫至80℃之後,再加入檸檬酸鈉水溶液(5.82克檸檬酸鈉溶於30克去離子水),繼續反應30分鐘使溶液慢慢變成黑色狀態,即得到表面塗覆有奈米銀粒子之聚苯乙烯乳膠顆粒。利用穿透式電子顯微鏡(TEM)觀察的結果請參閱第四圖,由於硝酸銀和檸檬酸鈉的量加入過多,因此反應所產生的銀過多,以至於許多銀都聚集在一起。 Referring to Table 4, the synthetic steps of the nano silver particle-containing polystyrene latex particles in the present embodiment are as follows: (1) 1 g of polystyrene latex particles (PS latex particles) obtained in the first embodiment are uniformly mixed with 25 g of deionized water. To form a polystyrene latex particle suspension; (2) placing a uniformly mixed polystyrene latex particle suspension into the reaction tank, raising the temperature to 90 ° C without stirring the condenser and flowing nitrogen; and continuously stirring; (3) mixing 0.3 g of silver nitrate (AgNO 3 ) with 15 g of deionized water to prepare an aqueous solution of silver nitrate; (4) adding a silver nitrate aqueous solution to the reaction tank at a temperature of 90 ° C (the reaction tank solution gradually becomes a goose yellow solution) ), to form a mixed solution, and for 1 hour; (5) after the mixed solution is cooled to 80 ° C, then add sodium citrate aqueous solution (5.82 grams of sodium citrate dissolved in 30 grams of deionized water), continue the reaction for 30 minutes The solution was slowly turned into a black state, that is, a polystyrene latex particle having a surface coated with nano silver particles was obtained. The results of observation by a transmission electron microscope (TEM) are shown in the fourth figure. Since the amount of silver nitrate and sodium citrate is excessively added, the reaction generates too much silver, so that many silver are aggregated.

實施例六Embodiment 6

請參閱表五,本實施例含奈米銀粒子聚苯乙烯乳膠顆粒合成步驟為(1)取實施例一製得之1g聚苯乙烯乳膠顆粒(PS乳膠顆粒)與25克去離子水混合均勻,以形成聚苯乙烯乳膠顆粒懸浮液;(2) 將混合均勻的聚苯乙烯乳膠顆粒懸浮液置入反應槽,在不接冷凝管及通氮氣下,將溫度升至90℃並持續攪拌;(3)將0.1g硝酸銀(AgNO3)與5g去離子水混合以製得硝酸銀水溶液;(4)於溫度95℃,將硝酸銀水溶液加入反應槽中(此時反應槽溶液會逐漸變成鵝黃色溶液),以形成一混合溶液,並作用1小時;(5)將混合溶液降溫至85℃之後,再加入檸檬酸鈉水溶液(1.94克檸檬酸鈉溶於10克去離子水),繼續反應30分鐘使溶液慢慢變成黑色狀態,即得到表面塗覆有奈米銀粒子之聚苯乙烯乳膠顆粒,其中聚苯乙烯乳膠顆粒之平均粒徑為390~990nm,奈米銀粒子之平均粒徑為5~100nm。利用穿透式電子顯微鏡(TEM)觀察的結果請參閱第五圖,因為進行合成時,加入適當含量的硝酸銀,且反應的時間長短適當,所以形成適當數量的銀,而且因為反應時間較久,所以銀顆粒可以有足夠的時間吸附在PS乳膠顆粒上,使得所產生的PS乳膠顆粒的表面上均勻的佈滿銀顆粒。 Referring to Table 5, the synthetic steps of the nano silver particle-containing polystyrene latex particles in the present embodiment are as follows: (1) 1 g of polystyrene latex particles (PS latex particles) obtained in the first embodiment are uniformly mixed with 25 g of deionized water. To form a polystyrene latex particle suspension; (2) placing a uniformly mixed polystyrene latex particle suspension into the reaction tank, raising the temperature to 90 ° C without stirring the condenser and flowing nitrogen; and continuously stirring; (3) 0.1g of silver nitrate (AgNO 3 ) is mixed with 5g of deionized water to prepare an aqueous solution of silver nitrate; (4) adding a silver nitrate aqueous solution to the reaction tank at a temperature of 95 ° C (the reaction tank solution gradually becomes a goose yellow solution). ) to form a mixed solution and act for 1 hour; (5) after cooling the mixed solution to 85 ° C, then add an aqueous solution of sodium citrate (1.94 g of sodium citrate dissolved in 10 g of deionized water), continue the reaction for 30 minutes The solution is slowly turned into a black state, that is, a polystyrene latex particle having a surface coated with nano silver particles, wherein the average particle diameter of the polystyrene latex particles is 390 to 990 nm, and the average particle diameter of the nano silver particles is 5 ~100nm. For the results observed by a transmission electron microscope (TEM), please refer to the fifth figure, because the appropriate amount of silver nitrate is added during the synthesis, and the reaction time is appropriate, so an appropriate amount of silver is formed, and because the reaction time is long, Therefore, the silver particles can have sufficient time to adsorb on the PS latex particles, so that the surface of the generated PS latex particles is uniformly covered with silver particles.

實施例七:最低抑菌濃度(MIC)試驗 Example 7: Minimum inhibitory concentration (MIC) test

取實施例六製得之含奈米銀粒子聚苯乙烯乳膠顆粒進行抑菌測試,以得知含奈米銀粒子聚苯乙烯乳膠顆粒的最低抑菌濃度(minimum inhibitory concentration,簡稱MIC)。所謂「最低抑菌濃度」即為測定能夠抑制90%培養基內的定量試驗菌株生長的最低樣品濃度值,MIC值越低代表樣品抑菌效果越佳。本實施例取革蘭氏 陽性菌-金黃色葡萄球菌(Staphylococcus aureus)與革蘭氏陰性菌-大腸桿菌(Escherichia coli)進行實驗。於無菌養菌管中分別加入不同濃度(0~0.020%)之抗菌樣品(含奈米銀粒子聚苯乙烯乳膠顆粒),再加入1c.c.之Nutrient broth或TSB培養液和已知菌種之菌液混合均勻;然後,將其置於37℃的培養箱中震盪培養一天。取培養後較為澄清養菌管之懸浮液,用連續十倍稀釋法,取適量滴於洋菜膠平板培養基上塗佈均勻,依其適當生長條件培養後,觀察並計算菌落產生之數量來決定MIC值。 The nano-silver particle-containing polystyrene latex particles prepared in Example 6 were subjected to a bacteriostatic test to find the minimum inhibitory concentration (MIC) of the nano-silver particle-containing polystyrene latex particles. The "minimum inhibitory concentration" is the minimum sample concentration value that can inhibit the growth of quantitative test strains in 90% of the medium. The lower the MIC value, the better the bacteriostatic effect of the sample. In this example, Gram-positive bacteria Staphylococcus aureus and Gram-negative bacteria Escherichia coli were used for experiments. Add different concentrations (0~0.020%) of antibacterial samples (including nano silver particle polystyrene latex particles) to the sterile culture tube, and then add 1c.c. Nutrient broth or TSB medium and known strains. The bacterial liquid was uniformly mixed; then, it was shaken and cultured in an incubator at 37 ° C for one day. After culturing, the suspension of the cultivating tube is clarified, and the appropriate ten-fold dilution method is applied to the agar vegetable plate medium for uniform coating. After culturing according to the appropriate growth conditions, the number of colony production is observed and calculated. MIC value.

結果請參閱第六圖,實施例六製得之含奈米銀粒子聚苯乙烯乳膠顆粒確實具有抑菌作用,對於金黃色葡萄球菌與大腸桿菌的最低抑菌濃度分別為0.0075%和0.011%。 The results are shown in the sixth figure. The nano-silver-containing polystyrene latex particles prepared in Example 6 have a bacteriostatic effect, and the minimum inhibitory concentrations for Staphylococcus aureus and Escherichia coli are 0.0075% and 0.011%, respectively.

由於本發明製得之聚苯乙烯乳膠顆粒具有銀粒子均勻地塗覆於聚苯乙烯乳膠顆粒表面,因此具有良好的抑菌效果,且由於該等銀粒子係牢固地附著於聚苯乙烯乳膠顆粒表面,不會任意脫離。因此,將含奈米銀粒子聚苯乙烯乳膠顆粒添加至化妝品中,不僅可以取代傳統防腐劑之添加,亦可解決微小的奈米銀穿過皮膚進入人體細胞之問題,並且可使該銀粒子達到奈米級分散,增進其抗菌功效。 Since the polystyrene latex particles obtained by the present invention have silver particles uniformly coated on the surface of the polystyrene latex particles, they have a good bacteriostatic effect, and since the silver particles are firmly attached to the polystyrene latex particles The surface will not be arbitrarily separated. Therefore, the addition of nano-silver particle polystyrene latex particles to cosmetics can not only replace the addition of traditional preservatives, but also solve the problem that tiny nano silver enters human cells through the skin, and can make the silver particles It achieves nano-scale dispersion and enhances its antibacterial effect.

綜上所述,本發明之含奈米銀粒子之高分子乳膠顆粒組成物,的確能藉由上述所揭露之實施例,達到所預期之使用功效,且本發明亦未曾公開於申請前,誠已完全符合專利法之規定與要求。爰依法提出發明專利之申請,懇請惠予審查,並賜准專利,則實感德便。 In summary, the nano-silver particle-containing polymer latex particle composition of the present invention can achieve the intended use efficiency by the above-disclosed examples, and the present invention has not been disclosed before the application. It has fully complied with the requirements and requirements of the Patent Law.爰Issuing an application for a patent for invention in accordance with the law, and asking for a review, and granting a patent, is truly sensible.

惟,上述所揭之圖示及說明,僅為本發明之較佳實施例,非為限定本發明之保護範圍;大凡熟悉該項技藝之人士,其所依本發明之特徵範疇,所作之其它等效變化或修飾,皆應視為不脫離本發明之設計範疇。 The illustrations and descriptions of the present invention are merely preferred embodiments of the present invention, and are not intended to limit the scope of the present invention; those skilled in the art, which are characterized by the scope of the present invention, Equivalent variations or modifications are considered to be within the scope of the design of the invention.

Claims (7)

一種含均勻分布奈米銀粒子之高分子乳膠顆粒組成物,係包括高分子乳膠顆粒及分散塗覆於該高分子乳膠顆粒表面之奈米銀粒子,其中該高分子乳膠顆粒之直徑為390-990nm,該奈米銀粒子之直徑為5-100nm,且該高分子乳膠顆粒與該奈米銀粒子重量百分比為1000:1至1:1;其中該組成物之製備方法為:將重量百分比3.84%之高分子乳膠顆粒懸浮液26克與重量百分比1.96%硝酸銀(AgNO3)水溶液5.1克均勻混合以形成一混合溶液,並於溫度95℃作用1小時;以及將該混合溶液降溫至80℃,再加入重量百分比16.25%之檸檬酸鈉水溶液11.94克於該混合溶液中作用0.5小時,以得到表面塗覆有奈米銀粒子之高分子乳膠顆粒組成物。A polymer latex particle composition containing uniform distribution of nano silver particles, comprising polymer latex particles and nano silver particles dispersed on the surface of the polymer latex particles, wherein the polymer latex particles have a diameter of 390- 990 nm, the diameter of the nano silver particles is 5-100 nm, and the weight percentage of the polymer latex particles and the nano silver particles is 1000:1 to 1:1; wherein the composition is prepared by: 3.84 by weight 26 g of the polymer latex particle suspension was uniformly mixed with 5.1 g of a 1.96% by weight aqueous solution of silver nitrate (AgNO 3 ) to form a mixed solution, and allowed to act at a temperature of 95 ° C for 1 hour; and the mixed solution was cooled to 80 ° C, Further, 11.94 g of a 16.25% by weight aqueous solution of sodium citrate was added to the mixed solution for 0.5 hour to obtain a polymer latex particle composition having a surface coated with nano silver particles. 如申請專利範圍第1項所述之含均勻分布奈米銀粒子之高分子乳膠顆粒組成物,其中該組成物具有球狀結構或橢圓形結構。The polymer latex particle composition containing uniformly distributed nano silver particles according to claim 1, wherein the composition has a spherical structure or an elliptical structure. 如申請專利範圍第1項所述之含均勻分布奈米銀粒子之高分子乳膠顆粒組成物,其中該組成物係用於抑制革蘭氏陽性菌、革蘭氏陰性菌及真菌之生長。The polymer latex particle composition containing uniform distribution of nano silver particles according to claim 1, wherein the composition is for inhibiting growth of Gram-positive bacteria, Gram-negative bacteria and fungi. 如申請專利範圍第1項所述之含均勻分布奈米銀粒子之高分子乳膠顆粒組成物,其中該高分子乳膠顆粒為聚苯乙烯(polystyrene)乳膠顆粒、聚甲基丙烯酸甲酯(polymethylmethacrylate)乳膠顆粒、聚甲基丙烯酸正丁酯(poly-n-butyl methacrylate)乳膠顆粒、苯乙烯與甲基丙烯酸甲酯共聚物之乳膠顆粒、苯乙烯與甲基丙烯酸正丁酯共聚物之乳膠顆粒,或甲基丙烯酸甲酯與甲基丙烯酸正丁酯共聚物之乳膠顆粒。The polymer latex particle composition containing uniformly distributed nano silver particles according to claim 1, wherein the polymer latex particles are polystyrene latex particles and polymethylmethacrylate. Latex particles, poly-n-butyl methacrylate latex particles, latex particles of styrene and methyl methacrylate copolymer, latex particles of styrene and n-butyl methacrylate copolymer, Or latex particles of a copolymer of methyl methacrylate and n-butyl methacrylate. 如申請專利範圍第4項所述之含均勻分布奈米銀粒子之高分子乳膠顆粒組成物,其中該高分子乳膠顆粒為聚苯乙烯乳膠顆粒。The polymer latex particle composition containing uniform distribution of nano silver particles according to claim 4, wherein the polymer latex particles are polystyrene latex particles. 如申請專利範圍第1項所述之含均勻分布奈米銀粒子之高分子乳膠顆粒組成物,係用於化妝品原料組成物及醫藥組成物。The polymer latex particle composition containing uniform distribution of nano silver particles as described in claim 1 is used for a cosmetic raw material composition and a pharmaceutical composition. 一種如申請專利範圍第1項所述之含均勻分布奈米銀粒子之高分子乳膠顆粒組成物於製備化妝品原料以及醫藥組成物之抗菌劑之用途,係用以抑制金黃色葡萄球菌(Staphylococcus aureus)與大腸桿菌(Escherichia coli),且對於金黃色葡萄球菌與大腸桿菌之最小抑菌濃度分別為0.0075%與0.011%。The use of a polymer latex particle composition containing uniformly distributed nano silver particles according to claim 1 for the preparation of a cosmetic raw material and an antibacterial agent for a pharmaceutical composition for inhibiting Staphylococcus aureus ) and Escherichia coli , and the minimum inhibitory concentrations for Staphylococcus aureus and Escherichia coli are 0.0075% and 0.011%, respectively.
TW104135206A 2015-10-27 2015-10-27 Polymer latex particle composition containing nano silver particles TWI640565B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW104135206A TWI640565B (en) 2015-10-27 2015-10-27 Polymer latex particle composition containing nano silver particles
US14/953,196 US9777125B2 (en) 2015-10-27 2015-11-27 Method for producing polymer latex particle coated with silver nanoparticles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW104135206A TWI640565B (en) 2015-10-27 2015-10-27 Polymer latex particle composition containing nano silver particles

Publications (2)

Publication Number Publication Date
TW201714945A TW201714945A (en) 2017-05-01
TWI640565B true TWI640565B (en) 2018-11-11

Family

ID=58558289

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104135206A TWI640565B (en) 2015-10-27 2015-10-27 Polymer latex particle composition containing nano silver particles

Country Status (2)

Country Link
US (1) US9777125B2 (en)
TW (1) TWI640565B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10719021B2 (en) * 2016-12-02 2020-07-21 Xerox Corporation Metallic toner comprising metal integrated particles
CZ308039B6 (en) * 2017-10-19 2019-11-13 Centrum organické chemie s.r.o. Stable aqueous antimicrobial dispersion, use of this dispersion, cosmetic emulsion and coating composition containing this dispersion
WO2019204468A1 (en) * 2018-04-18 2019-10-24 Sabic Global Technologies B.V. Magnetic nanoparticles embedded in polymer microparticles
CN108559237A (en) * 2018-05-02 2018-09-21 合肥市晨雷思建筑材料科技有限公司 A kind of antibacterial biological thin-film material and preparation method thereof
CN111449086A (en) * 2020-05-11 2020-07-28 武汉工程大学 Colloidal silver/polymer mixed disinfectant and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103788526A (en) * 2014-01-14 2014-05-14 鲁东大学 Preparation method of silver-loaded polymer microspheres
CN104086719A (en) * 2014-07-02 2014-10-08 齐鲁工业大学 Preparation method of ferroferric oxide/polystyrene/silver nano-composite particles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248772A (en) * 1992-01-29 1993-09-28 Coulter Corporation Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
TWI455718B (en) 2008-04-21 2014-10-11 Univ Nat Taiwan Nano silver particle/clay composite for antibacterial and manufacturing method thereof
TWI455778B (en) 2009-02-23 2014-10-11 Univ Vanung Method for producing metal nanoparticles bonded to substrate surface
JP5229187B2 (en) 2009-11-11 2013-07-03 信越化学工業株式会社 Silicone composite particles, production method thereof, and cosmetics

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103788526A (en) * 2014-01-14 2014-05-14 鲁东大学 Preparation method of silver-loaded polymer microspheres
CN104086719A (en) * 2014-07-02 2014-10-08 齐鲁工业大学 Preparation method of ferroferric oxide/polystyrene/silver nano-composite particles

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
M. Palomba et al., "Activity of Antimicrobial Silver Polystyrene Nanocomposites", Journal of Nanomaterials, Volume 2012, Article ID 185029, 7 pages *
M. Palomba et al., "Activity of Antimicrobial Silver Polystyrene Nanocomposites", Journal of Nanomaterials, Volume 2012, Article ID 185029, 7 pages。

Also Published As

Publication number Publication date
US20170114191A1 (en) 2017-04-27
TW201714945A (en) 2017-05-01
US9777125B2 (en) 2017-10-03

Similar Documents

Publication Publication Date Title
Zhou et al. Synthesis and characterization of silver nanoparticles-doped hydroxyapatite/alginate microparticles with promising cytocompatibility and antibacterial properties
Gunalan et al. Green synthesized ZnO nanoparticles against bacterial and fungal pathogens
Zhao et al. Highly stable graphene-based nanocomposite (GO–PEI–Ag) with broad-spectrum, long-term antimicrobial activity and antibiofilm effects
TWI640565B (en) Polymer latex particle composition containing nano silver particles
JP6423833B2 (en) Composition and method of antibacterial metal nanoparticles
Tran et al. Low cytotoxic trace element selenium nanoparticles and their differential antimicrobial properties against S. aureus and E. coli
Perelshtein et al. CuO–cotton nanocomposite: Formation, morphology, and antibacterial activity
Vijayakumar et al. Biosynthesis, characterisation and anti-bacterial effect of plant-mediated silver nanoparticles using Artemisia nilagirica
Krishnamoorthy et al. Nanostructured molybdenum oxide-based antibacterial paint: effective growth inhibition of various pathogenic bacteria
Zhang et al. Potent antibacterial activities of Ag/TiO2 nanocomposite powders synthesized by a one-pot sol− gel method
Podsiadlo et al. Layer-by-layer assembly of nacre-like nanostructured composites with antimicrobial properties
Dong et al. Modifying Fe3O4-functionalized nanoparticles with N-halamine and their magnetic/antibacterial properties
Perelshtein et al. Ultrasound radiation as a “throwing stones” technique for the production of antibacterial nanocomposite textiles
Khan et al. Antibacterial studies of ZnO and Cu-doped ZnO nanoparticles synthesized using aqueous leaf extract of Stachytarpheta jamaicensis
Mohammed et al. Assessment of antimicrobial activity of chitosan/silver nanoparticles hydrogel and cryogel microspheres
Roberson et al. Synthesis and characterization silver, zinc oxide and hybrid silver/zinc oxide nanoparticles for antimicrobial applications
Tian et al. Antibacterial applications and safety issues of silica‐based materials: A review
Soumya et al. Zinc oxide–curcumin nanocomposite loaded collagen membrane as an effective material against methicillin-resistant coagulase-negative Staphylococci
Li et al. Preparation and antibacterial performance testing of Ag nanoparticles embedded biological materials
CN102294492A (en) Polymer surface protection monodisperse nano silver particle and preparation method thereof
Parmar et al. Biogenic PLGA-Zinc oxide nanocomposite as versatile tool for enhanced photocatalytic and antibacterial activity
Uzair et al. Targeting microbial biofilms: by Arctium lappa l. synthesised biocompatible CeO2‐NPs encapsulated in nano‐chitosan
TWI588093B (en) Method for manufacturing polymer latex particle containing nano silver particles
Lei et al. Synergistic effect of Ag and Cu on improving in vitro biological properties of K2Ti6O13 nanowires for potential biomedical applications
Pica et al. Antimicrobial performances of some film forming materials based on silver nanoparticles

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees